|
KRTCAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4432899320127E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.50941498084012E-13 |
| Normal-vs-Stage2 |
7.780600E-03 |
| Normal-vs-Stage3 |
1.86153999999217E-05 |
| Normal-vs-Stage4 |
1.678300E-02 |
| Stage1-vs-Stage2 |
6.605600E-01 |
| Stage1-vs-Stage3 |
9.811200E-01 |
| Stage1-vs-Stage4 |
2.454200E-01 |
| Stage2-vs-Stage3 |
7.213200E-01 |
| Stage2-vs-Stage4 |
1.450990E-01 |
| Stage3-vs-Stage4 |
2.536000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44249065417534E-15 |
| Normal-vs-AfricanAmerican |
2.34249999997438E-06 |
| Normal-vs-Asian |
1.993640E-04 |
| Caucasian-vs-AfricanAmerican |
7.439600E-01 |
| Caucasian-vs-Asian |
7.528400E-01 |
| AfricanAmerican-vs-Asian |
8.732600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.44009282066327E-15 |
| Normal-vs-Female |
5.85189999791069E-08 |
| Male-vs-Female |
8.560200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.80420000004145E-07 |
| Normal-vs-Extreme_Weight |
2.01172412062078E-13 |
| Normal-vs-Obese |
1.22889999953912E-07 |
| Normal-vs-Extreme_Obese |
9.733700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.558400E-01 |
| Normal_Weight-vs-Obese |
1.089850E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.401600E-01 |
| Extreme_Weight-vs-Obese |
3.828200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.571000E-01 |
| Obese-vs-Extreme_Obese |
8.750600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.582100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.433519969396E-12 |
| Normal-vs-Age(61-80Yrs) |
4.38771241562108E-12 |
| Normal-vs-Age(81-100Yrs) |
5.242200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.053400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.353200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.228100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.732000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.151620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.722420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44089209850063E-16 |
| Normal-VS-Type2 PRCC |
3.93979999999683E-05 |
| Normal-VS-KIRP CIMP |
1.981880E-03 |
| Normal-VS-Unclassified PRCC |
2.195900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.327040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.639600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.271400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.516400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.786400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.144200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46659999980636E-07 |
| Normal-vs-N1 |
4.608200E-04 |
| Normal-vs-N2 |
2.283500E-02 |
| N0-vs-N1 |
2.254200E-01 |
| N0-vs-N2 |
5.141700E-02 |
| N1-vs-N2 |
4.594600E-01 |
|
|
